Updated:
Sagemoore Capital
Sagemoore Capital is a private equity firm focused on healthcare investments in the lower middle-market. The firm has made three investments, including a...
Sagemoore Capital
Sagemoore Capital is a private equity firm focused on healthcare investments in the lower middle-market. The firm has made three investments, including a Series A - II investment in Carie Health on September 30, 2018. Sagemoore Capital has one portfolio exit, Carie Health, which occurred on March 31, 2020.
General information
Firm type
Private Equity
Year founded
2014
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Stamford
Corporate office
Stamford, CT, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Sagemoore Capital?
Sagemoore does not publicly identify its principals or investment committee members. Its team page is password-protected and the firm has no active LinkedIn presence captured in this profile. Without disclosed leadership, who holds ultimate investment discretion remains unclear to outside allocators.
How does Sagemoore Capital source its deal flow?
Sagemoore sources primarily through its advisory funnel. It offers a free exit-readiness decision-analysis tool that draws in owner-operators considering a liquidity event. Once engaged on an advisory mandate to improve operations and valuation, the firm can transition the relationship into a capital deployment or sales-process role, creating a captive deal pipeline.
Does Sagemoore invest from a discretionary fund or deploy capital on a deal-by-deal basis?
The firm has not publicized a formal fund structure or disclosed its assets under management. Its website describes providing 'direct access to private capital' and support for add-on acquisitions, which suggests deal-by-deal or SPV-based deployment rather than a blind-pool commingled fund — but no definitive structure has been confirmed publicly.
What is Sagemoore’s approach to value creation before an exit?
Sagemoore promotes a programmatic methodology: it first identifies key operational improvement areas through an initial analysis, then supports the implementation of best practices. The firm claims this process can nearly double a company's value. It also maintains proprietary valuation software built on a database of past industry transactions to benchmark progress.
How is Sagemoore’s advisory business separated from its investment activities?
The firm lists an Advisory Services Group and an Investment Services Group as distinct offerings, but does not disclose a formal separation mechanism, compliance walls, or fee structures. Whether the advisory fees are discounted when the firm invests, or whether an advisory engagement obligates a founder to accept Sagemoore’s investment capital, is not addressed in public materials.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: